Clinical Trial Update: Pembrolizumab in Treating Participants With Leukoplakia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of pembrolizumab for leukoplakia variants is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythroleukoplakia
• Leukoplakia
• Verrucous Oral Leukoplakia

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Erythroleukoplakia, Leukoplakia | Phase 2 | Status: RECRUITING